Publication

Byline

Location

Beyond generics: Glenmark resets agenda with a bold 10-year pivot to global drug innovation, says chairman Saldanha

MUMBAI, July 7 -- A year after a landmark deal for an immunotherapy cancer drug with AbbVie, Glenmark Pharmaceuticals is planning a major strategic shift and doubling down to become a global innovatio... और पढ़ें